Post-Grant Proceedings Are Important For Biosimilars

In this IP Law360 article, Paul A. Calvo, Ph.D. and Eldora L. Ellison, Ph.D. discuss potential challenges facing biosimilar developers and the importance of post-grant patent challenges at the U.S. Patent and Trademark Office as a mechanism for obtaining early and fast patent certainty. 

To read the full article, download the attached PDF.